+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Accelerate Diagnostics Receives Fda Marketing Authorization For The Accelerate Pheno System And Accelerate Phenotest Bc Kit is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Accelerate Diagnostics Receives Fda Marketing Authorization For The Accelerate Pheno System And Accelerate Phenotest Bc Kit | RobinsPost News & Noticias

An FDA pathway can accelerate innovation for Duchenne muscular dystrophy


The FDA has made significant strides in following scientific data and reason to approve new treatments by using the accelerated approval program, beginning with eteplirsen, the first treatment for ... Read More

Accelerate Diagnostics Inc AXDX


Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Read More

Icecure seeks FDA authorization to market cryoablation system for breast cancer


Icecure Medical Ltd. submitted data to the U.S. FDA seeking de novo marketing authorization for its Prosense system to treat patients with early stage T1 invasive breast cancer in combination with ... Read More

Democrats Should Join the Call for FDA to Accelerate Approval of Smokefree Products


This expedited process for combustible cigarettes happens because the FDA treats authorization of nicotine ... applications are bottled up in the system along with nicotine pouches like Zyn ... Read More

Accelerate Diagnostics CEO sells shares worth over $20k


Accelerate Diagnostics, Inc (NASDAQ ... Each RSU represents a right to receive one share of common stock upon vesting. After these transactions, Phillips's ownership in the company stands at ... Read More

MMI Receives FDA Authorization to Commercialize Symani® Surgical System in the U.S.


De Novo Classification builds on proven clinical success and expands global access to new category of treatments JACKSONVILLE, Fla., April 08, 2024--(BUSINESS WIRE)--MMI (Medical Microinstruments ... Read More

An innovation showcase


BC research projects, including a 3-D 'gamification' of James Joyce's 'Ulysses,' to be displayed at Smithsonian's ACCelerate Festival ABOVE: A scene from JoyceStick, a 3-D 'gamification' of James ... Read More

Accelerate Diagnostics Inc.


The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ... Read More

Accelerate Diagnostics Inc AXDX


We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ... Read More

Accelerate Diagnostics Inc


For most investors, the best investment strategy is to buy good stocks and hold them for the long run. Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus